Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 31

1.

KPP: KEGG Pathway Painter.

Manyam G, Birerdinc A, Baranova A.

BMC Syst Biol. 2015;9 Suppl 2:S3. doi: 10.1186/1752-0509-9-S2-S3. Epub 2015 Apr 15.

2.

Age-independent rise of inflammatory scores may contribute to accelerated aging in multi-morbidity.

Stepanova M, Rodriguez E, Birerdinc A, Baranova A.

Oncotarget. 2015 Jan 30;6(3):1414-21.

3.

Can NASH lipidome provide insight into the pathogenesis of obesity-related non-alcoholic fatty liver disease?

Birerdinc A, Younossi Z.

J Hepatol. 2015 Apr;62(4):761-2. doi: 10.1016/j.jhep.2015.01.005. Epub 2015 Jan 17. No abstract available.

4.

Expression of energy metabolism related genes in the gastric tissue of obese individuals with non-alcoholic fatty liver disease.

Mehta R, Birerdinc A, Wang L, Younoszai Z, Moazzez A, Elariny H, Goodman Z, Chandhoke V, Baranova A, Younossi ZM.

BMC Gastroenterol. 2014 Apr 9;14:72. doi: 10.1186/1471-230X-14-72.

5.

Multiple factors predict physical performance in people with chronic liver disease.

Loria A, Doyle K, Weinstein AA, Winter P, Escheik C, Price J, Wang L, Birerdinc A, Baranova A, Gerber L, Younossi ZM.

Am J Phys Med Rehabil. 2014 Jun;93(6):470-6. doi: 10.1097/PHM.0000000000000050.

PMID:
24398583
6.

Host genetic variants in obesity-related nonalcoholic fatty liver disease.

Mehta R, Birerdinc A, Younossi ZM.

Clin Liver Dis. 2014 Feb;18(1):249-67. doi: 10.1016/j.cld.2013.09.017. Epub 2013 Oct 24. Review.

PMID:
24274878
7.

Adipose tissue as an endocrine organ.

McGown C, Birerdinc A, Younossi ZM.

Clin Liver Dis. 2014 Feb;18(1):41-58. doi: 10.1016/j.cld.2013.09.012. Review.

PMID:
24274864
8.

Molecular signature of adipose tissue in patients with both non-alcoholic fatty liver disease (NAFLD) and polycystic ovarian syndrome (PCOS).

Baranova A, Tran TP, Afendy A, Wang L, Shamsaddini A, Mehta R, Chandhoke V, Birerdinc A, Younossi ZM.

J Transl Med. 2013 May 31;11:133. doi: 10.1186/1479-5876-11-133.

9.

Expression of genes for microRNA-processing enzymes is altered in advanced non-alcoholic fatty liver disease.

Sharma H, Estep M, Birerdinc A, Afendy A, Moazzez A, Elariny H, Goodman Z, Chandhoke V, Baranova A, Younossi ZM.

J Gastroenterol Hepatol. 2013 Aug;28(8):1410-5. doi: 10.1111/jgh.12268.

PMID:
23663110
10.

Expression of inflammation-related genes is altered in gastric tissue of patients with advanced stages of NAFLD.

Mehta R, Birerdinc A, Neupane A, Shamsaddini A, Afendy A, Elariny H, Chandhoke V, Baranova A, Younossi ZM.

Mediators Inflamm. 2013;2013:684237. doi: 10.1155/2013/684237. Epub 2013 Mar 30.

11.

Protein partners of KCTD proteins provide insights about their functional roles in cell differentiation and vertebrate development.

Skoblov M, Marakhonov A, Marakasova E, Guskova A, Chandhoke V, Birerdinc A, Baranova A.

Bioessays. 2013 Jul;35(7):586-96. doi: 10.1002/bies.201300002. Epub 2013 Apr 17.

PMID:
23592240
12.

Quo vadis: from oxidative stress to gamma-glutamyltransferase upregulation to mortality.

Mehta R, Birerdinc A, Younossi Z.

J Clin Exp Hepatol. 2013 Mar;3(1):2-3. doi: 10.1016/j.jceh.2013.02.004. No abstract available.

13.

Knowledge-based identification of soluble biomarkers: hepatic fibrosis in NAFLD as an example.

Page S, Birerdinc A, Estep M, Stepanova M, Afendy A, Petricoin E, Younossi Z, Chandhoke V, Baranova A.

PLoS One. 2013;8(2):e56009. doi: 10.1371/journal.pone.0056009. Epub 2013 Feb 6.

14.

Gene expression profiles associated with depression in patients with chronic hepatitis C (CH-C).

Birerdinc A, Afendy A, Stepanova M, Younossi I, Baranova A, Younossi ZM.

Brain Behav. 2012 Sep;2(5):525-31. doi: 10.1002/brb3.72. Epub 2012 Jul 6.

15.

Manipulating molecular switches in brown adipocytes and their precursors: a therapeutic potential.

Birerdinc A, Jarrar M, Stotish T, Randhawa M, Baranova A.

Prog Lipid Res. 2013 Jan;52(1):51-61. doi: 10.1016/j.plipres.2012.08.001. Epub 2012 Aug 30. Review.

PMID:
22960032
16.

Non-alcoholic fatty liver disease (NAFLD) is associated with low level of physical activity: a population-based study.

Gerber L, Otgonsuren M, Mishra A, Escheik C, Birerdinc A, Stepanova M, Younossi ZM.

Aliment Pharmacol Ther. 2012 Oct;36(8):772-81. doi: 10.1111/apt.12038. Epub 2012 Sep 8.

PMID:
22958053
17.

[Selection of reliable reference genes for qRT-PCR analysis in human non-cancerous gastric tissue].

Birerdinc A, Mehta R, Alhussain R, Afendi A, Chandhoke V, Younossi Z, Baranova A.

Mol Biol (Mosk). 2012 Jan-Feb;46(1):166-75. Russian.

PMID:
22642115
18.

Do-It-Yourself device for recovery of cryopreserved samples accidentally dropped into cryogenic storage tanks.

Mehta R, Baranova A, Birerdinc A.

J Vis Exp. 2012 May 11;(63):e3903. doi: 10.3791/3903.

19.

Gene expression profiles associated with anaemia and ITPA genotypes in patients with chronic hepatitis C (CH-C).

Birerdinc A, Estep M, Afendy A, Stepanova M, Younossi I, Baranova A, Younossi ZM.

J Viral Hepat. 2012 Jun;19(6):414-22. doi: 10.1111/j.1365-2893.2011.01564.x. Epub 2011 Dec 7.

PMID:
22571903
20.

The impact of IL28B genotype on the gene expression profile of patients with chronic hepatitis C treated with pegylated interferon alpha and ribavirin.

Younossi ZM, Birerdinc A, Estep M, Stepanova M, Afendy A, Baranova A.

J Transl Med. 2012 Feb 7;10:25. doi: 10.1186/1479-5876-10-25.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk